Fig. 6
From: Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway

TSPO protected against mitochondrial dysfunction and pyroptosis by enhancing AMPK-PGC1α pathway. A Schematic diagram of the experimental flow. B Western blot showing the expression levels of TSPO, p-AMPK, AMPK, PGC-1α, MFN2 and TFAM after inhibition of AMPK. C Representative transmission electron microscopy images of mitochondria after inhibition of AMPK, scale bar = 2 μm. D, E ELISA results showing the levels of the IL-1β and the IL- after inhibition of AMPK, n = 6 per group. F Western blot showing the expression levels of NLRP3, Caspase-1 and GSDMD-N after inhibition of AMPK. G Representative immunofluorescence images showing c-Fos and NeuN co-staining after inhibition of AMPK. H Behavioral testing of von Frey after inhibition of AMPK at different time points (days 0, 3, 7, 14, and 21), n = 10 per group. Data are represented as mean ± SEM, ***p < 0.001